
The Pharma Stock Surging Amid Industry Uncertainty
SpringWorks Therapeutics (NASDAQ:SWTX) specializes in cancer and rare diseases, marking its presence with the FDA-approved OGSIVEO for desmoid tumors. The company achieved a remarkable 65.65% year-to-date performance, highlighting its potential amidst industry uncertainties. Despite no confirmed mergers, potential collaborations with industry giants